BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
US |
|
T
|
Thai Beverage PCL
XBER:T6W
|
TH |
|
F
|
F-Secure Oyj
F:3I6
|
FI |
|
Brinks Co
NYSE:BCO
|
US |
|
N
|
Newtek Business Services Corp
F:1N31
|
US |
|
Billington Holdings PLC
LSE:BILN
|
UK |
|
Bukit Asam Tbk PT
IDX:PTBA
|
ID |
|
B
|
Banco Santander Brasil SA
F:DBSA
|
BR |
|
F
|
Freemelt Holding AB (publ)
STO:FREEM
|
SE |
|
Europcar Mobility Group SA
F:E7CD
|
FR |
|
B
|
Builders FirstSource Inc
XBER:B1F
|
US |
Shareholder Yield
Current shareholder yield for BCRX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BCRX Price
BioCryst Pharmaceuticals Inc
| Average Annual Return | -12.31% |
| Standard Deviation of Annual Returns | 31.35% |
| Max Drawdown | -79% |
| Market Capitalization | 2.4B USD |
| Shares Outstanding | 254 160 000 |
| Percentage of Shares Shorted | 19.3% |
